SCHEMBL8280439

SCHEMBL8280439

CN[C@H](C(=O)O)C1(C)CCCCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
MME P08473 2/20 0.33
CYP2C9 P11712 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
FFAR3 O14843 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
DPP4 P27487 1/20 0.30
FAP Q12884 1/20 0.30
PITRM1 Q5JRX3 1/20 0.30
DPP8 Q6V1X1 1/20 0.30
DPP9 Q86TI2 1/20 0.30
DPP7 Q9UHL4 1/20 0.30
CYP3A4 P08684 1/20 0.30
CETP P11597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5415303 0.98 TSHR (0.32) TSHRNFKB1CYP2C19MMECYP2C9
SCHEMBL18771632 0.98 TSHR (0.34) TSHRNFKB1CYP2C19MMEFFAR3
SCHEMBL18789723 0.83 SMN1; SMN2 (0.35) TSHRCYP2C9MAPK1SMN1; SMN2ALDH1A1
SCHEMBL14899073 0.83 SMN1; SMN2 (0.35) TSHRCYP2C9MAPK1SMN1; SMN2ALDH1A1
SCHEMBL8279345 0.82 CETP (0.33) TSHRNFKB1CYP2C19MMECYP2C9
SCHEMBL14827615 0.79 TSHR (0.34) TSHRNFKB1CYP2C19MMECYP2C9
SCHEMBL583878 0.73 CTSK (0.39) MEN1KMT2A
SCHEMBL1492103 0.73 CTSK (0.39) MEN1KMT2A
SCHEMBL583877 0.73 CTSK (0.39) MEN1KMT2A
SCHEMBL8670866 0.73 CYP2C19 (0.38) TSHRNFKB1CYP2C19MMESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005087721-A2 COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-09-22 WO disclosed
WO-2005085242-A1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-09-15 WO disclosed